INTRODUCTION
Th e mucosa of the gastrointestinal and respiratory tracts comprise the largest surfaces in contact with the external milieu. Th is system is designed to provide a physico-chemical barrier against dissemination of pathogenic mircroorganisms while sampling a vast array of foreign antigens, presenting them to the immune system, and adapting them to the presence of foreign microbial communities. 1 In addition to pattern recognition 
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IMMUNO-EPIDEMIOLOGY OF TB
Th e intracellular pathogen M. tuberculosis has co-existed in human populations for at least 50,000 years. 11 Spread from person to person via aerosol droplets, M. tuberculosis infects one-third of the world ' s population, or over 2 billion people. Despite dramatic declines in incidence and prevalence of TB infection in industrialized countries, there are over 8 million new cases of M. tuberculosis , 1.5 million deaths, and 40 million new infections each year. 12 Although TB typically occurs in poor socio-economic conditions, even under these circumstances, a competent human immune system is equipped to control the infection. Of those exposed to TB, only 30 % 13, 14 are thought to develop the state of latent infection, during which the host remains clinically well, but bacilli survive within T-cell activated granulomas in a dormant or slowly replicating state. 15 Of those harboring a latent infection, on average, only 5 -10 % will progress to active clinical disease, the majority within 2 -3 years of exposure. Approximately 50 % of those with active disease will survive without treatment, although each could infect an additional 10 -20 contacts during the period of active disease. 12, 16 Protective immunity to TB is predominately cell-mediated and incompletely understood. Although the precise mechanisms are controversial, TLR-mediated innate immunity and microbicides present in the airways, and are likely to play a role in resistance during the initial phases of acute infection. 17 Th e only vaccine currently in use, the live attenuated M. bovis -derived Bacille -CalmetteGuerin (BCG) vaccine, stimulates a wide spectrum of cellular immune responses, but has highly variable effi cacy, and does not protect against adult pulmonary disease. 18, 19 Based on animal models of BCG vaccination, T-cell recall responses are delayed approximately 2 weeks postchallenge, representing a significant delay in T-cell priming. 20 For this reason, mucosal Th 17 vaccines based on early recruitment of neutrophils with production of interleukin (IL)-17 and mediators such as IL-23 in the alveolar passages are a promising area of investigation. 9 Mucosally administered TB vaccines may off er properties superior to the intramuscular route. 21 With the establishment of latent M. tuberculosis infection, a network of pro-infl ammatory and regulatory circuits is invoked to sequester bacilli-infected macrophages within granulomae. Both tumor necrosis factor-and interferon (IFN)-derived from activated T cells appear to be essential for maintaining the integrity of granulomae and preventing reactivation. 22 Central memory T-cells expressing IL-2 also appear to be important for clearance of infection and resolution of fi brosis. 23 -25 To circumvent these defenses, M. tuberculosis inhibits phagolysomic fusion and acidification within macrophages. 15, 26 In household-contact biomarker studies, early progression has been associated with alterations in the production of regulatory Th -2 cytokines, such as IL-4 and IL-10. 27,28 Th us, the balance of eff ector and suppressive immune responses appears to be important in the host ' s prolonged management of TB infection. 29 In longitudinal studies, many acquired immuno-suppressive conditions are known to disrupt this balance 34 and anti-tumor necrosis factortherapy. 35 With insights from systems biology models, a dynamic spectrum of TB infection, continuously mediated by micro-environmental factors, has been postulated. 17, 36 Understanding the role of concurrent mucosal infections like H. pylori and gastro-intestinal helminthiasis may lead to better delineation of this spectrum.
INTESTINAL HELMINTHS AND
M. TUBERCULOSIS
Over a quarter of the world ' s population is infected with the soil-transmitted intestinal helminths, including the roundworm Ascaris lumbricoides , the hookworms Necatoramericanus and Ancylostomaduodenale , the whipworm Trichuristrichiura , and Enterobiusvermicularis , and Strongyloides spp. 37, 38 Despite their species diversity, gastrointestinal helminths (and also many non-mucosalworms) elicit a stereotypic human immune response. Classically, this is characterized by secretion of IgE and IgG4 isotype with concurrent eosinophilia, 39 and polarization of CD4 + T cells towards a Th 2 phenotype, 40 -42 on which expulsion depends. 43 Th is " modifi ed " Th 2 phenotype is associated with production of the cytokines IL-4, IL-9, IL-10, IL-13, 44 as well as induction of Foxp3 + Treg cells and regulatory cytokines TGF-and IL-10. 45 In endemic regions, worm burdens tend to peak by adolescence, suggesting the development of partial resistance with age. 40 Conversely, the virtual disappearance of helminths from the human microbiome of high-income countries has been linked with the rise in atopic and auto-immune conditions, 46 possibly due to eff ects on Treg induction. Based on these fi ndings, helminth-based therapies for conditions such as multiple sclerosis and infl ammatory bowel disease are an active area of investigation. 47, 48 Although there are few studies, epidemiological evidence suggests that helminth infections may diminish immune responses to TB antigens. In humans, chronic intestinal helminathiasis is associated with immune hypo-responsiveness, 49,50 including a " bystander effect " , to oral cholera 51, 52 and BCG vaccines. 53 In a randomized control trial, Elias et al. 54 reported that albendazole deworming was associated with signifi cant improvements in purifi ed protein derivative-induced IFN-production following BCG vaccination of Ethiopian adults. In a second trial, this team also reported that co-infected adults not receiving anti-helminthic treatment had increased production of PPD-induced TGF-3 months following BCG vaccination. 53 In a Brazilian cohort, TB patients with intestinal parasites had lower IFNand higher IL-10 levels compared with TB patients without intestinal parasites. 55 In in vitro T-cell functional studies in blood from Indonesian school children, researchers found that geohelminthassociated regulatory T-cell responses suppressed IFN-responses to BCG and Plasmodium falciparum , an eff ect that was reversed with removal of CD4 + CD25 hi T cells. 56 Th ese studies off er evidence that both infl ammatory and regulatory signals involved in control of TB infection can be modifi ed by concurrent intestinal helminth infection. Some fi larial worms and tissue-invasive cestodes, beyond the scope of this commentary, are also thought to aff ect responsiveness to mycobacterial antigens, although the mechanisms may diff er. 49 Although environmental mycobacteria are widely considered to block immune responses to TB antigens, 57 their distribution does not account for the wide variability in responses to BCG. Th e role of concurrent helminth infections needs to be more systematically explored in the context of TB vaccine and immunogenicity trials.
H. PYLORI AND M. TUBERCULOSIS
H.pylori , a bacterium that colonizes the gastric mucosa and epithelial lining of the human stomach, remains one of the most common chronic mucosal infections in the world, 58 infecting approximately 80 % of those in TB-endemic regions. Typically acquired in early life via oral -oral or fecal -oral pathways, 59 chronic infection is now known to be the preeminent cause of gastric cancer and peptic ulcer disease. 60 -62 All infected hosts develop a superfi cial gastritis that typically persists asymptomatically for many decades. In addition to specifi c IgA, IgM, and IgG responses, this gastritis is associated with induction of IL-8 by epithelial cells, 63 as well as a locally vigorous, cell-mediated immune response, characterized by increased mucosal concentrations of the infl ammatory cytokines IFN-, tumor necrosis factor-, IL-1 , and IL-6. 64 Th e cytokine IL-12 is present in large numbers of mononuclear cells and appears to be involved in differentiating naive T-cells into a Th 1 phenotype. 65 Although the predominate profile during infection is infl ammatory, the IL4 antagonist, IL-4 2, T-regulatory-activated IL-10, as well as B-cell responses, may be permissive for chronic H. pylori colonization via counter-regulatory mechanisms. 66 Th e role of IL-17 in infl ammation and recruitment of neutrophils at the site of infection is an area of intense investigation. 67, 68 As helminth infections vary with respect to their immunological eff ects, so too, H. pylori strains elicit diff erent immune responses. 69 Of particular note, some H. pylori strains contain a pathogenicity island, 70 a 30-gene cassette encoding a Type IV secretion system that translocates virulence factors to the host cytosol. 71 Th is pathogenicity island induces increased inflammation with higher risk of ulcer disease 72 and gastric cancers. 73, 74 Host polymorphisms are also thought to exacerbate this interaction. 75 Other differences in H. pylori strain, such as expression of the active form of the immunogenic vacuolating antigen 76 or preservation of the outer membrane protein BabA (which mediates adhesion to human Le b blood group antigens), may also infl uence immunological reactions by aff ecting attachment and neutrophil recruitment. 64 Dramatic declines in the incidence of H. pylori infection occurring in industrialized regions during the twentieth century have corresponded with increases in the prevalence of allergy-like symptoms 77 as well as upper gastrointestinal diseases. 78 Th ese trends have prompted some investigators to speculate that in regions of high infant mortality, immune-regulated H. pylori infection confers survival advantages against deadlier infections of early childhood. 79 For example, in Northern nature publishing group COMMENTARIES Californian Hispanic households, H. pylori infection was associated with protection from household gastroenteritis. 80 Th at concurrent helminth infection has been observed to alter the infl ammatory response to H. pylori in rodent 81 and human 82 studies could support the notion that the two infections exert competitive regulatory eff ects on cellmediated immunity when present in the same host.
Because social conditions contributing to the prevalence of M. tuberculosis and H. pylori are similar, cross-sectional studies of disease association tend to yield confl icting results. 83, 84 Few studies have correlated immune responses to H. pylori and TB infection in co-infected hosts. In a preliminary fi nding, we have reported that Northern Californians seropositive for H. pylori and testing positive for latent TB have enhanced IFN-production and a dominant Th 1-type cytokine profi le in response to specifi c TB antigens. 85 We also reported that, compared with latently infected household contacts who did not progress to active TB disease during 2 years of follow-up, Gambian TB patients were one-third as likely to be H. pylori seropositive. However, in Gambian and Pakistani household contacts exposed to an infectious case of TB, baseline H. pylori infection was not associated with secondary case activation aft er 2 years. In cynomolgus macaques, those with natural H. pylori infection were one-third as likely to progress to TB 6 -8 months aft er M. tuberculosis challenge. 85 Although these lines of investigation provide preliminary evidence of enhanced immunity to TB with H. pylori infection, challenges in study design remain to be overcome. Th ese include the relatively poor predictive value of immunodiagnostics in the setting of primary progressive TB, 86 the need to identify more prevalent intermediate markers of progression, and the suboptimal performance of H. pylori serology in the developing world. 85 If H. pylori influences the immune response to TB infection, there are several possible mechanisms. For example, H. pylori could promote a " Th2 -Th1 switch " in early life, such that Th 1-type responses to an unrelated MALT infection are permanently heightened. Such a " hygiene hypothesis " has been proposed for hepatitus A virus. 87 Studies comparing BCG immunogenicity in infants and adolescents from developing and industrialized countries also support this type of phenomenon. 88 In a second model, active, asymptomatic, H. pylori gastritis would provide a continuous source of infl ammatory stimulation. Such a " bystander " model was recently described for mice infected with mucosal herpes viridae and protected from subsequent challenge by Y. pestis and L. monocytogenes . Th is model may apply uniquely to chronic mucosal infections. 89 Th ough more speculative, H. pylori -induced IL-17 might have a role in early T-cell recruitment to the lung compartment, thereby enhancing initial resistance to latent TB infection. Another possibility is that dysregulation of the H. pylori -associated gastric T-regulatory system compromises systemic Th1 responses involved in control of a TB infection. In separate laboratory studies, the IL-4 inhibitor, IL4 2 splice variant, has been implicated both in upregulation of the Th 1 dominant H. pylori Cag A response 90 and downregulation of the Th 2-mediated response associated with progression of latent TB infection. 91 
TOWARD A MICROBIOMIC PERSPECTIVE
Th e human immune system has evolved in the face of a panoply of commensal and mutual infections. 92 Classic mucosal defenses, including organogenesis of lymphoid follicles, induction of secretory IgA, and recruitment of the cell-mediated armentarium appear to be seeded and orchestrated by the establishment of microbrial communities in early life. 93, 94 Growing evidence implicates the human microbiome as a major regulator of immunopathologies associated with diverse conditions such as infl ammatory bowel disease, 95 obesity, 96 allergies, 97 and even psychopathology. 98 Understanding the interactions of naturally occurring mucosal infections such as H. pylori , intestinal helminths, and M. tuberculosisthree distinct parasitic infections present in the same ecosystem for millennia, exerting contrasting immunoregulatory eff ects, to which the normal human immune is substantially adapted -off ers a potentially informative " microbiomic " perspective for vaccine and immunodiagnostic research. The evidence presented here remains preliminary and belies the need for more original work. Th e research infrastructure now assembled for TB vaccine trials provides a well-organized platform to roll out interdisciplinary prospective studies of major public health importance.
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